RecruitingPhase 3NCT07745504
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Sponsor: Novo Nordisk A/S
Oak Park, IL · +10 more sites
1 recruiting obesity studies with a site in Oak Park, IL.
Sponsor: Novo Nordisk A/S
Oak Park, IL · +10 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.